Impact of resistance to thyroid hormone on the cardiovascular system in adults

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 2812-2816

  Pulcrano, Melania ^a   Palmieri, Emiliano Antonio ^b   Mannavola, Deborah ^c   Ciulla, Michele ^d   Campi, Irene ^c   Covelli, Danila ^c   Lombardi, Gaetano ^a   Biondi, Bernadette ^a   Beck Peccoz, Paolo ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Division of Cardiology   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART RATE; HORMONE RESISTANCE; HUMAN; MALE; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 68549090634     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0096     Document Type: Article

References (44)

1. Refetoff S, Weiss RE, Usala SJ 1993 The syndrome of resistance to thyroid hormone. Endocr Rev 14:348-399
2. Refetoff S, Weiss RE 2000 Resistance to thyroid hormone. Rev Endocr Metab Disord 1:97-108
3. Gurnell M, Beck-Peccoz P, Chatterjee VK 2006 Resistance to thyroid hormone. In: DeGroot LJ, Jameson JL. Endocrinology. 5th ed. Chicago: Elsevier; 2227-2237
4. Beck-Peccoz P, Mannavola D, Persani L 2005 Syndromes of thyroid hormone resistance. Ann Endocrinol (Paris) 66:264-269
5. Adams M, Matthews C, Collingwood TN, Tone Y, Beck-Peccoz P, Chatterjee K 1994 Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. J Clin Invest 94:506-515
6. Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, Weintraub B 1995 Genetic and clinical features of 42 kindreds with resistance to thyroid hormone: the national institutes of health prospective study. Ann Intern Med 123:572-583
7. Beck-Peccoz P, Chatterjee VK 1994 The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225-232
8. Oetting A, Yen PM 2007 New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 21:193-208
9. Refetoff S, Dumitrescu AM 2007 Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 21:277-305
10. Johansson C, Gothe S, Forrest D, Vennstrom B, Thoren P 1999 Cardiovascular phenotype and temperature control in mice lacking thyroid hormone receptor-β or both α1 and β. Am J Physiol 276:2006-2012
11. Salto C, Kindblom JM, Johansson C, Wang Z, Gullberg H, Nordstrom K, Mansen A, Ohlsson C, Thoren P, Forrest D, Vennstrom B 2001 Ablation of TR α2 and a concomitant over expression of α1 yields a mixed hypo- and hyperthyroid phenotype in mice. Mol Endocrinol 15:2115-2128
12. Mansen A, Larsson L, Forrest D, Vennstrom B 2001 TRs have common and isoform-specific functions in regulation of cardiac myosin heavy chain genes. Mol Endocrinol 15:2106-2114
13. O'Shea PJ, Williams GR 2002 Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol 175:553-570
14. Pazos-Moura C, Abel ED, Boers ME, Moura E, Hampton TG, Wang J, Morgan JP, Wondisford F 2000 Cardiac dysfunction caused by myocardium-specific expression of a mutant thyroid hormone receptor. Circ Res 86:700-706
15. Swanson EA, Gloss B, Belke DD, Kaneshige M, Cheng SY, Dillmann WH 2003 Cardiac expression and function of thyroid receptor β and its PV mutant. Endocrinology 144:4820-4825
16. Gloss B, Trost SU, Bluhm WF, Swanson EA, Clark R, Winkfein R, Janzen KM, Giles W, Chassande O, Samarut J, Dillmann WH 2001 Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor α or β Endocrinology 142:544-550
17. Ciulla MM, Paliotti R, Cortelazzi D, Tortora G, Barelli MV, Buonamici V, Magrini F, Beck-Peccoz P 2001 Effects of thyroid hormones on cardiac structure: a tissue characterization study in patients with thyroid disorders before and after treatment. Thyroid 11:613-619
18. Kahaly GJ, Matthews CH, Mohr-Kahaly S, Richards CA, Chatterjee KK 2002 Cardiac involvement in thyroid hormone resistance. J Clin Endocrinol Metab 87:204-212
19. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
20. Kahaly GJ, Dillmann WH 2005 Thyroid hormone action in the heart. Endocr Rev 26:704-728
21. Mannavola D, Vannucchi G, Fugazzola L, Cerutti N, Persani L, Beck-Peccoz P 2002 Genetic analyses and evaluation of peripheral parameters of thyroid hormone action for the differential diagnosis of RTH. A novel heterozygous missense mutation (M334T) discovered. J Endocrinol Invest 25:RC4-RC6
22. Sahn DJ, DeMaria A, Kisslo J, Weyman A 1978 Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083
23. Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G, Saccà L, Bellastella A, Lombardi G 1993 Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77:334-338
24. Devereux RB 1987 Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation standardization and comparison to other methods. Hypertension 9:19-26
25. Teichholz LE, Kreulen T, Herman MV, Gorlin R 1976 Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 37:7-11
26. Colan SD, Borow KM, Neumann A Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 4:715-724
27. Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bonè F, Lombardi G, Saccà L 1999 Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84:2064-2067
28. O'Rourke MF, Gallagher DE 1996 Pulse wave analysis. J Hypertens 14:147-157
29. Vargas F, Moreno JM, Rodriguez-Gomez I, Wangensteen R, Osuna A, Alvarez-Guerra M, Garcia-Estan J 2006 Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol 154:197-212
30. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F 2003 Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731-3737
31. Gloss B, Sayen MR, Trost SU, Bluhm WF, Meyer M, Swanson EA, Usala SJ, Dillmann WH 1999 Altered cardiac phenotype in transgenic mice carrying the Δ337 threonine thyroid hormone receptor β mutant derived from the S family. Endocrinology 140:897-902
32. Klein I 1988 Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol. Endocrinology 123:203-210
33. Balkman C, Ojamaa K, Klein I 1992 Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 130:2001-2006
34. Biondi B, Palmieri EA, Lombardi G, Fazio S 2002 Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904-914
35. Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F, Mariotti S 2000 Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 85:159-164
36. Shargorodsky M, Serov S, Gavish D, Leibovitz E, Harpaz D, Zimlichman R 2006 Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma. Thyroid 16:381-386
37. Kinugawa K, Jeong MY, Bristow MR, Long CS 2005 Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor α1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. Mol Endocrinol 19:1618-1628.
38. Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves ML 2003 Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol 285:R1473-R1480
39. Weiss RE, Korcarz C, Chassande O, Cua K, Sadow PM, Koo E, Samarut J, Lang R 2002 Thyroid hormone and cardiac function in mice deficient in thyroid hormone receptor-α or -β: an echocardiograph study. Am J Physiol Endocrinol Metab 283:E428-E435
40. Ortiga-Carvalho TM, Hashimoto K, Pazos-Moura CC, Geenen D, Cohen R, Lang RM, Wondisford FE 2004 Thyroid hormone resistance in the heart: role of the thyroid hormone receptor β isoform. Endocrinology 145:1625-1633
41. Miller LD, McPhie P, Suzuki H, Kato Y, Liu ET, Cheng SY 2004 Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Genome Biol 5:R31-R42
42. Ojamaa K, Klemperer JD, Klein I 1996 Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6:505-512
43. Kahaly GJ, Kampmann C, Mohr-Kahaly S 2002 Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid 12:473-481
44. Biondi B, Palmieri EA, Lombardi G, Fazio S 2002 Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 87:968-974